Senior Manager, CMC Quality
Alto Neuroscience
Senior Manager, CMC Quality
Alto Neuroscience
AI-driven precision psychiatric drug development
About Alto Neuroscience, Inc.
At Alto Neuroscience, you will play a pivotal role in advancing precision psychiatry and improving how mental health disorders are treated. Join us in building the next generation of personalized neuroscience-based therapeutics.
Primary Role
We are seeking an experienced Director/Senior Manager, CMC Quality to provide quality oversight for Chemistry, Manufacturing, and Controls (CMC) and Clinical Supplies activities across Alto's drug substances, drug products, and packaged products, ensuring GMP compliance and inspection readiness as programs move toward registrational and eventually commercial manufacturing. Level will flex based on candidate experience.
What you'll do
Quality Oversight
Cross-Functional CMC Support
Systems Build
Location
Preferred: Mountain View, CA (hybrid). Remote considered for the right candidate.
Salary Range
$165-180k, Senior Manager
$215-240k, Director
*depending on qualifications and experience level
Travel Required
Periodic travel to the CDMO/Clinical Packaging sites and home office for company-wide meetings.
Qualifications
Required Skills/Abilities:
Required (Director level)
Required (Senior Manager level)
Alto Neuroscience is an equal-opportunity employer that does not discriminate on the basis of sex, age, race, color, religion, marital status, sexual orientation, gender identity, pregnancy, disability, or any other characteristic protected by law. We offer a welcoming and inclusive environment in service to one another, our products, the diverse consumers we represent, and the communities we call home. We do all of this with kindness, empathy and respect for each other. The above is intended to describe the general content of and requirements for the performance of this job. It should not be construed as an exhaustive statement of duties, responsibilities or physical requirements.
[]
AI-driven precision psychiatric drug development
Alto Neuroscience develops AI-guided precision psychiatric drugs. It uses brain biomarkers and clinical data to match patients to specific Alto drug candidates. The approach aims to improve outcomes with personalized, biology-based selection and relies on ongoing clinical trials and regulatory approval. The business model centers on developing and commercializing these drugs for the psychiatric market once approved.
Explore more opportunities at Alto Neuroscience